Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort

por Pistor, Maximilian, Hammer, Helly, Salmen, Anke, Hoepner, Robert, Friedli, Christoph
Publicado 2022

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis

por Marti, Stefanie, Hoepner, Andreas G. F., Hammer, Helly, Salmen, Anke, Chan, Andrew, Hoepner, Robert
Publicado 2023

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

por Friedli, Christoph, Diem, Lara, Hammer, Helly, Kamber, Nicole, Suter-Riniker, Franziska, Leib, Stephen, Chan, Andrew, Hirzel, Cédric, Hoepner, Robert, Salmen, Anke
Publicado 2021

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

por Hammer, Helly, Hoepner, Robert, Friedli, Christoph, Leib, Stephen L., Suter-Riniker, Franziska, Diem, Lara, Kamber, Nicole, Chan, Andrew, Salmen, Anke, Kamm, Christian P.
Publicado 2022

Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study

por Diem, Lara, Schwarzwald, Anina, Friedli, Christoph, Hammer, Helly, Gomes‐Fregolente, Livia, Warncke, Jan, Weber, Lea, Kamber, Nicole, Chan, Andrew, Bassetti, Claudio, Salmen, Anke, Hoepner, Robert
Publicado 2022

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

por Diem, Lara, Fregolente-Gomes, Livia, Warncke, Jan D., Hammer, Helly, Friedli, Christoph, Kamber, Nicole, Jung, Simon, Bigi, Sandra, Funke-Chambour, Manuela, Chan, Andrew, Bassetti, Claudio L., Salmen, Anke, Hoepner, Robert
Publicado 2022